0001179110-17-009549.txt : 20170623
0001179110-17-009549.hdr.sgml : 20170623
20170623205328
ACCESSION NUMBER: 0001179110-17-009549
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170621
FILED AS OF DATE: 20170623
DATE AS OF CHANGE: 20170623
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OvaScience, Inc.
CENTRAL INDEX KEY: 0001544227
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 451472564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 FOURTH AVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-500-2802
MAIL ADDRESS:
STREET 1: 9 FOURTH AVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GILLIS JONATHAN
CENTRAL INDEX KEY: 0001709954
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35890
FILM NUMBER: 17928765
MAIL ADDRESS:
STREET 1: 9 FOURTH AVENUE
STREET 2: C/O OVASCIENCE, INC.
CITY: WALTHAM
STATE: MA
ZIP: 02451
3
1
edgar.xml
FORM 3 -
X0206
3
2017-06-21
0
0001544227
OvaScience, Inc.
OVAS
0001709954
GILLIS JONATHAN
C/O OVASCIENCE INC.
9 FOURTH AVE.
WALTHAM
MA
02451
0
1
0
0
Vice President Finance
Stock Option (right to buy)
14.27
2023-09-10
Common Stock
10000
D
Stock Option (right to buy)
10.09
2024-03-05
Common Stock
10000
D
Stock Option (right to buy)
42.10
2025-03-03
Common Stock
7500
D
Stock Option (right to buy)
6.96
2026-03-03
Common Stock
4000
D
Stock Option (right to buy)
1.64
2027-01-05
Common Stock
1000
D
Stock Option (right to buy)
1.49
2027-03-02
Common Stock
15000
D
The shares underlying this option vested as to 25% of the shares on September 10, 2014, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
The shares underlying this option vested as to 25% of the shares on March 5, 2015, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
The shares underlying this option vested as to 25% of the shares on March 3, 2016, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
The shares underlying this option vested as to 25% of the shares on March 3, 2017, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
12.5% of the shares underlying this option vested on April 5, 2017 and as to an additional 12.5% of the shares underlying this option shall vest at the end of each successive three month period thereafter until January 5, 2019.
The shares underlying this option shall vest as to 25% of the shares on March 2, 2018, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
Exhibit 24.1 - Power of Attorney
/s/ William C. Hicks, Attorney-in-fact
2017-06-23
EX-24
2
ex24_gillis.txt
Exhibit 24.1
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes
and appoints of Michelle Dipp, Executive Chair
of OvaScience, Inc. (the "Company"), and William C.
Hicks, Caroline G. Gammill,
Peter Cunningham and Anne Leland, each of
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., the Company's
oustide corporate counsel,signing singly, with full power of
substitution, the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, forms and authentication
documents for EDGAR Filing Access;
(2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such forms
and authentication documents;
(3) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer, director and/or 10% shareholder of the Company,
Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities
Exchange Act of 1934 and the rules thereunder;
(4) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such
Form 3, 4 or 5 and timely file such form with the United States Securities
and Exchange Commission and any stock exchange or similar authority; and
(5) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit
to, in the best interest of, or legally required by, the undersigned, it
being understood that the documents executed by such attorney-in-fact, on
behalf of the undersigned pursuant to this Power of Attorney, shall be in
such form and shall contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact,
or such attorney-in-fact's substitute or substitutes, shall lawfully do or
cause to be done by virtue of this power of attorney and the rights and powers
herein granted.The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, is not assuming, nor is the Company assuming, any of the
undersigned'responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed this 21th day of June, 2017.
/s/ Jonathan Gillis
Jonathan Gillis